CAT
Caterpillar Inc.
CAT has the edge over NVRI overall, supported by stronger fundamentals.
NVRI
Enviri Corporation
NVRI offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
NVRI Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Weak | |
| Weak |
NVRI's revenue, profitability, cash flow and balance sheet are all currently weak.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.
NVRI PE Valuation
NVRI has no meaningful PE right now: it lost money over the past year.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
CAT has the edge over NVRI on the outlook, with more favorable revenue expectations.
NVRI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong decline | |
| Improving | |
| Limited | |
| High |
Analysts expect NVRI's losses to shrink, with revenue declining.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.32 | +19% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT has the edge over NVRI on earnings quality, reporting a profit while its opponent remains loss making.
NVRI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$15.29 | -$11.95 |
| Q2 2026 | -$15.66 | -$12.44 |
| Q1 2026 | -$3.15 | -$1.46 |
| Q4 2025 | -$3.34 | -$1.75 |
| Q3 2025 | -$3.34 | -$2.11 |
| Q2 2025 | -$3.22 | -$2.01 |
| Q1 2025 | -$1.69 | -$0.51 |
| Q4 2024 | -$1.59 | -$0.51 |
NVRI lost $15.29 per share over the past year, a bigger loss than the year before.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT has the edge over NVRI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over NVRI on profitability, with a higher operating margin.
NVRI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $325M | -50% |
| Q2 2026 | $187.3M | -41% |
| Q1 2026 | $549.8M | +0.3% |
| Q4 2025 | $359.1M | -36% |
| Q3 2025 | $643.8M | +12% |
| Q2 2025 | $316M | -48% |
| Q1 2025 | $547.9M | -8.7% |
| Q4 2024 | $558.7M | -6.8% |
NVRI's revenue has slid since its 2025 peak: $325M last quarter, down 50% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.2% | -8.2 points |
| Q2 2026 | -130% | -123 points |
| Q1 2026 | 0.1% | -6 points |
| Q4 2025 | -61% | -53 points |
| Q3 2025 | 15% | +14 points |
| Q2 2025 | -7.7% | -14 points |
| Q1 2025 | 6.1% | -1.1 points |
| Q4 2024 | -7.8% | -3.4 points |
NVRI's operating margin was 7.2% last quarter, down 8.2 points from the same quarter a year ago.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT has the edge over NVRI on cash generation, producing positive trailing cash flow while its opponent burns cash.
NVRI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$28.2M | -1153% |
| Q2 2026 | -$331.6M | -$314.5M |
| Q1 2026 | -$12.2M | +$23.5M |
| Q4 2025 | -$10.5M | -683% |
| Q3 2025 | $2.7M | +$42.4M |
NVRI has burned cash in most quarters: −$382M over the past year, against −$48M the year before.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has 461M diluted shares, down 2.1% from a year ago, with $8.1B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
NVRI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.7% | +754K shares |
| 1 year | -65% | -52M shares |
| 3 years | -64% | -51.2M shares |
| 5 years | -64% | -51.6M shares |
| Available history | -64% | -51.6M shares |
NVRI has the edge over CAT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has more cash than debt.
NVRI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 37.0x | High |
| Q4 2025 | 32.9x | High |
| Q3 2025 | 6.9x | High |
| Q2 2025 | 11.7x | High |
| Q1 2025 | 7.8x | High |
| Q4 2024 | 6.7x | High |
| Q3 2024 | 5.7x | High |
| Q2 2024 | 5.2x | High |
NVRI's net debt is more than 20 years of its operating earnings (EBITDA), up from 7.8 years a year ago.
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
NVRI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.7 | Neutral |
| Stochastic | 59.2 | Neutral |
NVRI's weekly RSI is 50 (neutral) and its Stochastic is 59 (neutral).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.3% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
NVRI PE vs Industrials Sector
NVRI has no meaningful PE right now: it lost money over the past year.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
NVRI has stronger trend alignment. CAT is above 2 of 5 weekly averages versus NVRI above 2 of 2.
NVRI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $20.5 | 18% above |
| 20 week MA | $21.4 | 13% above |
NVRI is in an uptrend: it's above all two of its weekly moving averages, and 13% above its 20-week average.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has finished every year since 2020 higher, and it's up 3.8% so far in 2026.
NVRI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2026 YTD | $20.8 | $24.3 | +17% |
NVRI has the edge over CAT on returns for 2026, with the stronger performance.